SynBioBeta Speaker
Kexin Huang
Phylo
Co-founder & CEO
Kexin Huang is the co-founder and CEO of Phylo, the company behind Biomni Lab, the first Integrated Biology Environment where scientists collaborate with AI agents to accelerate scientific discovery. Phylo has raised a $13.5M seed round led by Andreessen Horowitz and Menlo Ventures' Anthology Fund.Before founding Phylo, Kexin was a PhD student in Computer Science at Stanford, advised by Jure Leskovec at the Stanford AI Lab, where he led the Biomni research project that Phylo spun out of. His research focused on building AI systems that produce novel, trustworthy, and interpretable biomedical discoveries — from multi-modal biological modeling to agentic reasoning for automating day-to-day research tasks. He has spent time researching at Genentech, GSK, Pfizer, Dana-Farber, and Rockefeller University.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Kexin
This Year
Session lineup still growing
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Featuring
Speaker Coming Soon
